Severe Aplastic Anaemia in the Nordic Countries: a Population Based Study of Incidence, Presentation, Course, and Outcome

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 1996 Apr 1

PMID 8669932

Citations 8

Authors

N Clausen

A Kreuger

T Salmi

G Johannesson

Affiliations

Soon will be listed here.

Abstract

Purpose: Incidence data for severe aplastic anaemia (SAA) in children are scanty and vary. Few population based studies have been reported. A retrospective and prospective study was conducted to determine the incidence and course of SAA.

Patients And Methods: All children with a diagnosis of SAA in the Nordic countries from 1982 through 1993 were registered and have been followed up since 1987.

Results: A total of 101 children were diagnosed with SAA. The mean annual child population was 4.31 million. A constant incidence of 1.95/million children/year was found: 2.4 for boys and 1.5 for girls. A non-significant increase of cases occurred from November to March. Possible aetiological agents were noted in 29%. The actuarial survival was 79% after one year and 68% after five years without significant difference between boys and girls.

Conclusion: The incidence of SAA in the Nordic countries remains stable with a preponderance among boys. SAA has still a high initial mortality and a risk of late deaths.

Citing Articles

Modified Delphi panel consensus recommendations for management of severe aplastic anemia.

Babushok D, DeZern A, de Castro C, Rogers Z, Beenhouwer D, Broder M Blood Adv. 2024; 8(15):3946-3960.

PMID: 38669341 PMC: 11331724. DOI: 10.1182/bloodadvances.2023011642.

Aplastic Anaemia in Pregnancy: A Case-Based Comprehensive Review of the Literature.

Perolla A, Cela B, Semanaj V, Dedej-Kurti T, Caja T Cureus. 2024; 16(4):e58365.

PMID: 38628381 PMC: 11019473. DOI: 10.7759/cureus.58365.

Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.

Vaht K, Goransson M, Carlson K, Isaksson C, Lenhoff S, Sandstedt A Haematologica. 2017; 102(10):1683-1690.

PMID: 28751565 PMC: 5622852. DOI: 10.3324/haematol.2017.169862.

IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.

Lin F, Karwan M, Saleh B, Hodge D, Chan T, Boelte K Blood. 2014; 124(25):3699-708.

PMID: 25342713 PMC: 4263980. DOI: 10.1182/blood-2014-01-549527.

Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients.

Babushok D, Li Y, Roth J, Perdigones N, Cockroft J, Biegel J Am J Hematol. 2013; 88(10):862-7.

PMID: 23798465 PMC: 3983712. DOI: 10.1002/ajh.23521.

References

BOTTIGER L, WESTERHOLM B . Aplastic anaemia. I. Incidence and aetiology. Acta Med Scand. 1972; 192(4):315-8. View

Khatib Z, Wilimas J, Wang W . Outcome of moderate aplastic anemia in children. Am J Pediatr Hematol Oncol. 1994; 16(1):80-5. View

Bayever E, Champlin R, Ho W, Lenarsky C, Storch S, Ladisch S . Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr. 1984; 105(6):920-5. DOI: 10.1016/s0022-3476(84)80078-5. View

SEIP M, Vidnes J . Cyclosporine A in a case of refractory severe aplastic anaemia. Scand J Haematol. 1985; 34(3):228-30. DOI: 10.1111/j.1600-0609.1985.tb02782.x. View

Szklo M, SENSENBRENNER L, Markowitz J, Weida S, Warm S, Linet M . Incidence of aplastic anemia in metropolitan Baltimore: a population-based study. Blood. 1985; 66(1):115-9. View

Clausen N . A population study of severe aplastic anemia in children. Incidence, etiology and course. Acta Paediatr Scand. 1986; 75(1):58-63. DOI: 10.1111/j.1651-2227.1986.tb10157.x. View

Cartwright R, McKinney P, Williams L, Miller J, Evans D, Bentley D . Aplastic anaemia incidence in parts of the United Kingdom in 1985. Leuk Res. 1988; 12(6):459-63. DOI: 10.1016/0145-2126(88)90111-7. View

Mary J, Baumelou E, Guiguet M . Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1990; 75(8):1646-53. View

Malkin D, Koren G, Saunders E . Drug-induced aplastic anemia: pathogenesis and clinical aspects. Am J Pediatr Hematol Oncol. 1990; 12(4):402-10. DOI: 10.1097/00043426-199024000-00004. View

10.

Camitta B, Doney K . Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. Am J Pediatr Hematol Oncol. 1990; 12(4):411-24. DOI: 10.1097/00043426-199024000-00005. View

11.

Issaragrisil S, Sriratanasatavorn C, Piankijagum A, Vannasaeng S, Porapakkham Y, Leaverton P . Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Blood. 1991; 77(10):2166-8. View

12.

Matloub Y, BRUNNING R, Arthur D, Ramsay N . Severe aplastic anemia preceding acute lymphoblastic leukemia. Cancer. 1993; 71(1):264-8. DOI: 10.1002/1097-0142(19930101)71:1<264::aid-cncr2820710140>3.0.co;2-8. View

13.

Baumelou E, Guiguet M, Mary J . Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1993; 81(6):1471-8. View

14.

Nissen C, Gratwohl A, Tichelli A, Stebler C, Wursch A, Moser Y . Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia. Br J Haematol. 1993; 83(2):319-25. DOI: 10.1111/j.1365-2141.1993.tb08288.x. View

15.

Camitta B, Thomas E, Nathan D, Gale R, Kopecky K, Rappeport J . A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979; 53(3):504-14. View